Stämm
Main Vertical
BioTech, FoodTech, Industry 4.0
Website
CEO/FOUNDER
Name and Surname
Yuyo Llamazares Vegh
Linkedin Profile or Bio
Name and Surname
Federico D'Alvia Vegh
Linkedin Profile or Bio
Number of people on the Staff
200
Legal Form
Public Limited Company (SA)
Year of Founding
2016
Type of Company
ScaleUp
Development Stage
International Expansion
Province
City of Buenos Aires
City
Retiro
Main Business Model
B2B
Problem
Stämm solves the problem of infrastructure shortages for biological production, which limits access to critical therapies such as antibodies and cell therapies. Faced with growing demand and costly, inflexible, and centralized traditional biomanufacturing, Stämm proposes a new infrastructure: compact, autonomous, continuous, and closed bioprocessors that enable the scaling of bioproducts in a decentralized, efficient, and sustainable manner.
Solutions Offered - Summary
Easy, continuous, scalable and automated biomanufacturing solutions
Solutions Offered - Details
Stämm develops advanced biomanufacturing solutions, centered on its continuous, bubble-free Bioprocessor that enhances yields, reduces costs, and minimizes footprint and energy use. Its offerings include AI-powered transomics platform for precise cell analysis and solutions for cell line development, enabling scalable, sustainable, and efficient biologics and cell therapies production.
Technologies Used
3D Printing, Artificial Intelligence, Automation, Big Data or Data Analytics, Internet of Things (IoT), Machine or Deep Learning, Simulation, Synthetic Biology, Web Platform, Other
Counterparties of Interest abroad
End Customer
Industries served
Agriculture, AgTech, Biotechnology, FoodTech, GreenTech, HealthTech, Industry 4.0, Laboratories, Manufacturing, Pharmaceutical, Renewable Energies
International Presence
GERMANY, UNITED STATES, ISRAEL, SWITZERLAND
Investment Round:
Series B
Certifications
N/A
Awards/Recognitions
N/A
Presentation
E-mail
info@stamm.bio